Life Expectancy at Birth

What Is Life Expectancy?

Life expectancy at birth is the average number of years a newborn infant can expect to live if subjected throughout its life to the age-specific mortality rates observed in a given year. It is the single most widely cited indicator of a population's overall health status and is used by governments, international organisations, and researchers to assess the effectiveness of healthcare systems, track long-term improvements in living standards, and compare well-being across countries.

The measure is a statistical construct, not a forecast. It does not predict how long any particular child born today will actually live, because mortality rates will almost certainly change over the course of that child's lifetime. What it does capture is a snapshot of current mortality conditions, distilled into one intuitive number. A country where life expectancy is 82 years has lower mortality at every age, on average, than one where life expectancy is 75 years.

Life expectancy has risen dramatically over the past century in virtually all countries, driven by improvements in sanitation, nutrition, medical care, and public health. In most advanced economies, the figure now exceeds 80 years, though gains have slowed in recent decades as the easy victories — reducing infant mortality, controlling infectious diseases — have largely been achieved and remaining progress depends on more difficult and expensive interventions against chronic and degenerative conditions.

The indicator carries an outsized influence on policy. It shapes pension-system design, healthcare resource allocation, retirement-age legislation, and actuarial calculations for insurance and annuity markets. A one-year change in life expectancy, compounded across an entire population, translates into billions of dollars in fiscal and financial commitments.

How It Is Calculated

Life expectancy is derived from a period life table, which organises age-specific mortality rates for a given year into a cohort-survival framework. The calculation proceeds in several steps.

For each age $x$, the age-specific mortality rate is:

$m_x = \frac{D_x}{P_x}$

where $D_x$ is the number of deaths at age $x$ during the year and $P_x$ is the mid-year population at age $x$. These rates are then converted into probabilities of dying within each age interval, and from those probabilities a hypothetical cohort — typically of 100,000 newborns — is traced through successive ages.

At each age, some members of the cohort die according to the observed mortality rate and the remainder survive to the next age. The life expectancy at birth is the average age at death across the entire hypothetical cohort:

$e_0 = \frac{\sum_{x=0}^{\omega} L_x}{l_0}$

where $L_x$ is the number of person-years lived by the cohort between exact ages $x$ and $x+1$, $l_0$ is the initial cohort size (100,000), and $\omega$ is the oldest age attained. The summation of $L_x$ across all ages gives the total person-years lived by the cohort, and dividing by the initial size yields the average lifespan.

Period versus Cohort Life Expectancy

The standard measure described above is period life expectancy, which applies a single year's mortality rates to a synthetic cohort. An alternative, cohort life expectancy, tracks an actual birth cohort through its entire life and computes observed average longevity. Cohort life expectancy is conceptually cleaner but can only be calculated for cohorts that have already died out, making it a historical rather than a current indicator. For policy and planning purposes, period life expectancy is the standard measure.

Because period life expectancy freezes mortality at current levels, it tends to understate how long people will actually live in an era of improving medical technology. Cohort life expectancy for recent generations is expected to be higher, which has implications for the adequacy of pension and retirement savings.

Healthy Life Expectancy

A refinement that has gained prominence is healthy life expectancy (or disability-free life expectancy), which subtracts years lived in poor health from total life expectancy. This measure addresses the concern that longer life may simply mean more years of chronic illness or disability rather than more years of active, productive living.

Healthy life expectancy is computed by weighting the person-years in the life table by health-state valuations drawn from survey data. The gap between total life expectancy and healthy life expectancy — the number of years lived in poor health — is itself an important indicator of healthcare-system performance and quality of life in old age.

Life Expectancy at Other Ages

While life expectancy at birth is the headline measure, statistical agencies also publish life expectancy at age 65, which is more directly relevant for pension planning and retirement policy. Because it conditions on having survived to 65, this figure is not affected by infant and child mortality and reflects only the mortality conditions that retirees face.

How to Read the Numbers

The table below provides an interpretive guide for life expectancy at birth across the global spectrum.

Within a single country, life expectancy can vary significantly by sex, region, ethnicity, and socioeconomic status. Women typically live four to seven years longer than men in most societies, a gap attributed to biological, behavioural, and occupational factors. Regional disparities within large countries can span a decade or more, reflecting differences in healthcare access, environmental quality, and lifestyle.

Income-based gaps are equally striking: in several advanced economies, the difference in life expectancy between the richest and poorest deciles exceeds ten years. This gradient underscores the extent to which health outcomes are shaped by socioeconomic circumstances and not merely by the quality of the healthcare system.

Year-to-year fluctuations are usually small — a few tenths of a year — making any sudden drop or stagnation highly informative. The opioid crisis, the COVID-19 pandemic, and rising "deaths of despair" have all produced visible dips in life expectancy in affected countries, serving as early warnings of public-health failures.

Economic Significance

Life expectancy is both a cause and a consequence of economic development. Healthier populations are more productive: workers who live longer and in better health accumulate more human capital, miss fewer workdays, and contribute to the economy for more years. Countries that invest in healthcare, nutrition, and sanitation enjoy higher labour productivity and faster economic growth, creating a virtuous cycle between health and prosperity.

From a fiscal perspective, rising life expectancy interacts directly with the sustainability of public pension systems. When people live longer than the actuarial assumptions embedded in pension design, the cost of providing retirement income increases. This dynamic is one of the primary reasons that governments periodically raise statutory retirement ages — an adjustment that effectively recalibrates the pension system to reflect improved longevity.

Healthcare spending is closely linked to life expectancy, though the relationship is nonlinear. At lower income levels, modest increases in health spending yield large gains in longevity. At higher levels, the marginal return diminishes: the most expensive interventions — advanced cancer therapies, intensive neonatal care, end-of-life treatment — extend life by months rather than years. Understanding this diminishing-returns curve is central to health-policy debates about resource allocation.

Life expectancy also influences household saving behaviour. In countries where people expect to live longer, the rational response is to save more during working years to finance a longer retirement. This demographic saving motive is one of the structural forces that economists cite when explaining persistently low real interest rates in aging societies.

For international investors and development agencies, life expectancy serves as a proxy for institutional quality and governance. Countries that deliver rising longevity tend to have functioning public-health systems, effective regulatory frameworks, and a degree of social stability that supports long-term economic planning. A stagnating or declining life expectancy, by contrast, may signal institutional decay, public-health crises, or deepening social inequality.

The labour-market implications of rising life expectancy are increasingly important. As people live longer and remain healthy further into traditional retirement ages, the potential labour supply expands. Policies that facilitate continued employment for older workers — through flexible work arrangements, retraining programmes, and age-discrimination protections — can help convert longer lives into longer productive careers, easing the fiscal burden of aging.

Related Indicators

• Health Spending as % of GDP — total resources devoted to healthcare, a key determinant of health outcomes
• Population Growth — influenced by mortality trends that life expectancy summarises
• Dependency Ratio — rising longevity directly increases the elderly share of the population
• GDP Per Capita — the income measure most closely correlated with life expectancy across countries